What can be expected from the ophthalmic devices market? Which areas are going to grow at the fastest rates? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.
Our 205-page report provides 176 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions.
Forecasts from 2015-2025 and other analyses show you commercial prospects Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis), product profiles and commercial developments. Read the full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including: • Ellie Bai, Press Relations Officer, Taiwan Liposome Company • Martina Iniotri, Ophthalmic Specialist, JINS Eyewear Inc.
See revenue forecasts for the leading international markets How will leading national markets perform to 2025? Our study forecasts ophthalmic device revenues in national markets, including: • US • Japan • China • Russia • Germany • France • Spain • UK • Italy • Rest of Europe • Brazil • Mexico • India • Rest of the World
Leading companies and potential for market growth Overall world revenue for ophthalmic devices market will reach $18bn in 2015, our work forecasts. We predict strong revenue growth through to 2025. The ageing population in many of the world’s largest markets will combine with a shift towards newer and more expensive lenses which will drive sales to 2025.
Our work analyses the key companies in the market. See Visiongain’s analysis of 10 leading ophthalmic device companies, including these: • Johnson and Johnson • Alcon (Novartis) • Coopervision • Bausch and Lomb (Valeant) • Abbot Medical • Hoya Corporation • Topcon • Carl Zeiss Meditec • Nidek Co. • STAAR Surgical
A company profile gives you the following information where available: • Historical revenues from 2013 to 2014 • Discussion of a company’s activities and outlook • Recent financial results • Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
Research and development – assess innovation, trends and possibilities What about R&D – the pipeline for new devices? You see trends for these areas and technologies: • Smart Lens technology • Ocular drug delivery devices • Highly efficient surgical devices and suites
The R&D pipeline for surgical devices is particularly strong, with faster and more precise machines being in demand. These are not revolutions in the technology and may not allow for new surgeries to be performed, but instead increase the efficiency of current surgeries.
What issues will affect the ophthalmic devices industry? Our new report discusses issues and events affecting the ophthalmic devices market. You will find discussions, including qualitative analyses: • Highly challenging payment environment • Rapidly advancing technology leading to quickly eroding profit margins • The rise of pharmaceutical treatments for a number of ophthalmic diseases
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices report helps you In summary, our 205-page report gives you the following knowledge: • Revenue forecasts to 2025 for the global ophthalmic devices market – discover the industry’s prospects, finding promising places for investments and revenues • Revenue forecasts to 2025 for the leading regional ophthalmic device markets – US, Japan, China, Russia, UK, Germany, Italy, Spain, France, Rest of Europe, Brazil, India, Mexico, South Korea and Rest of the World • Predicted revenues of the leading national markets for contact lenses to 2025 – see potentials of top products • Assessment of 11 leading companies – hear about products, results and strategies including pipeline analysis and recent developments • Review of R&D pipelines – investigate developmental trends and progress • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market • View opinions from our survey, seeing interviews with authorities
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the ophthalmic devices market and leading companies. You find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview
1.1 Global Ophthalmic Devices Market Overview
1.2 Why You Should Buy This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Reports
1.9 About Visiongain
2. Introduction to the Ophthalmic Devices Market
2.1 The Eye: An Overview of Its Structure and Function
2.2 The Global Burden of Eye Disease
2.3 The Diagnosis and Surgical Treatment for Eye Diseases
2.3.1 Refractive Errors (Myopia, Hyperopia or Astigmatism)
2.3.1.1 LASIK Eye Surgery (Laser In-Situ Keratomileusis)
2.3.1.2 Phakic Intraocular Surgery
2.3.1.3 Photorefractive Keratectomy (PRK)
2.3.1.4 Conductive Keratoplasty (CK)
2.3.1.5 Refractive Lens Exchange (RLE)
2.3.2 Cataracts
2.3.2.1 Phacoemulsification and Intraocular Lenses
2.3.2.2 Microincision Cataract Surgery (MICS)
2.3.3 Glaucoma
2.3.3.1 Diagnosis of Glaucoma
2.3.3.2 Glaucoma Surgical Treatment
2.3.4 Age-Related Macular Degeneration (AMD)
2.3.4.1 Dry (non-exudative) AMD
2.3.4.1.1 Treatment for Dry AMD
2.3.4.2 Wet (exudative) AMD
2.3.4.3 Surgical Treatment of Wet AMD
2.3.4.3.1 Photodynamic Therapy
2.3.4.3.2 Laser Photocoagulation
2.3.4.3.3 Radtiotherapy – Oraya Therapy
2.3.4.3.4 Newer Types of Surgery
2.3.4.3.5 Wet AMD: Poor Outcomes with Surgical Procedures
2.3.5 Diabetic Retinopathy (DR)
2.3.5.1 Diagnosis of Diabetic Retinopathy
2.3.5.2 Treatment of Diabetic Retinopathy
2.3.6 Dry Eye Syndrome (DES)
2.3.6.1 Treatment of DES
2.3.6.1.1 Punctal Occlusion
2.3.6.1.2 Salivary Gland Autotransplantation
2.3.6.1.3 Tarsorrphaphy
2.4 Ophthalmic Devices
2.4.1 What are Ophthalmic Devices?
2.4.2 Devices: Classification
2.4.2.1 The US Medical Devices Classification System
2.4.2.2 The EU Medical Devices Classification System
2.4.2.3 The Japanese Medical Devices Classification System
2.4.3 Regulation of Ophthalmic Devices
2.4.3.1 The US Approval and Regulation System
2.4.3.2 The EU Approval and Regulation System
2.4.3.3 The Japanese Approval ad Regulation System
2.5 Ophthalmic Devices: Market Segmentation
2.5.1 The Monitoring and Diagnostics Ophthalmic Devices Market
2.5.1.1 General Eye Health
2.5.1.2 Refractive Monitoring and Diagnostic Devices
2.5.1.3 Glaucoma Monitoring and Diagnostic Devices
2.5.2 The Surgical Ophthalmic Devices Market
2.5.2.1 Cataract Surgery Devices
2.5.2.2 Glaucoma Surgery Devices
2.5.2.3 Refractive Error Surgery Devices
2.5.2.4 Vitreoretinal Surgery Devices
2.5.3 The Vision Care Devices Market
3. The Global Ophthalmic Devices Market 2015-2025
3.1 The Medical Devices Market Overview
3.1.1 The Global Medical Devices Market, 2015-2025
3.2 The Ophthalmic Devices Market by Submarket, 2014
3.3 The Ophthalmic Devices Market, 2015-2025
4. The Ophthalmic Vision Care Devices Market, 2015-2025
4.1 The Ophthalmic Vision Care Devices Market Overview
4.2 The Ophthalmic Vision Care Devices Market, 2015-2025
4.2.1 The Ophthalmic Vision Care Devices Market by Segment
4.2.1.1 The Ophthalmic Vision Care Devices Market by Segment, 2014
4.2.1.2 The Ophthalmic Vision Care Devices Market by Segment, 2015-2025
4.2.1.2.1 The Daily Disposable Contact Lens Market, 2015-2025
4.2.1.2.2 The Others Contact Lenses Market, 2015-2025
4.3 The Leading National Vision Care Market Forecast, 2015-2025
4.3.1 The Leading National Vision Care Markets, 2014
4.3.2 The Leading National Vision Care Market Forecast, 2015-2025
4.3.2.1 The US Vision Care Market Forecast, 2015-2025
4.3.2.2 The EU Vision Care Market Forecast, 2015-2025
4.3.2.3 The Chinese Vision Care Market Forecast, 2015-2025
4.3.2.4 The Japanese Vision Care Market Forecast, 2015-2025
4.3.2.5 The Russian Vision Care Market Forecast, 2015-2025
4.3.2.6 The Brazilian Vision Care Market Forecast, 2015-2025
4.3.2.7 The Indian Vision Care Market Forecast, 2015-2025
4.3.2.8 The South Korean Vision Care Market Forecast, 2015-2025
4.3.2.9 The Mexican Vision Care Market Forecast, 2015-2025
4.3.2.10 The Rest of the World Vision Care Market Forecast, 2015-2025
4.4 Contact Lenses on the Market
4.5 The Contact Lens Market: New Product Development and Product Pipeline
Figure 8.3 Alcon Vision Care Segment: Revenue Share(%) by Subsegment, 2014
Figure 8.4 Abbott Medical Devices: Revenue Share (%) by Segment, 2014
Figure 8.5 Bausch and Lomb: Surgical and Contact Lens Revenues as Share of Total US Revenue ($m), 2014
Figure 8.6 Bausch and Lomb: US revenue as a Percentage of Total Global Revenue, (%), 2014
Figure 8.7 Bausch and Lomb: Surgical and Contact Lens US revenue as Percentage of US revenue, with US Revenue as a Percentage of Total Global Revenue, (%), 2014
Figure 8.8 J&J Major Medical Devices: Revenue Share (%) by Segment, 2014
Figure 8.9 Nidek: Share of Revenue by Segment (%), 2013
Figure 8.10 Nidek: Share of Revenue by Location (%), 2013
Figure 8.11 Hoya: Sales Percentage by Region (%), 2014
Figure 8.12 Hoya: Revenue Share (%) by Segment, 2014
Figure 8.13 STAAR: Revenue Share (%) by Region, 2014
Figure 8.14 STAAR: Revenue Share (%) by Product, 2014
Figure 8.15 Carl Zeiss Meditec: Revenue Share (%) by Business Unit, 2014
Figure 8.16 Carl Zeiss Meditec: Revenue Share (%) by Region, 2014
Figure 8.17 TopCon: Revenue Share (%) by Company, 2014
Figure 9.1 Porter’s Five Forces Analysis of the Ophthalmic Devices Market, 2015-. 2025
Figure 11.1 World Ophthalmic Devices Market: Revenue ($bn) by Submarket, 2014-. 2015
Figure 11.2 World Ophthalmic Devices Market: Revenue ($bn), 2014-2025
Abbott Medical Optics, Inc.
Alcon (Novartis International AG)
Alimera Sciences, Inc.
Allergan/Actavis PLC
Aquesys, Inc.
Bausch and Lomb (Valeant Pharmaceuticals International, Inc.)
Calhoun Vision, Inc.
Canon, Inc.
Carl Zeiss Meditec AG
CooperVision
Essilor International S.A.
Forus Health Pvt. Ltd.
Genentech, Inc.
Glaukos Corporation
Google, Inc.
Heidelberg Engineering GmbH
Hoya Corporation
InSight
Ivantis, Inc.
Johnson & Johnson
LENSAR, Inc.
Marco
Medennium, Inc.
NeoMedix Corporation
Neurotech Pharmaceuticals, Inc.
Nidek Co., LTD.
Nikon Corporation
Novartis International AG
NuLens
Ocular Therapeutix, Inc.
Optovue, Inc.
Oraya Therapeutics International, Inc.
OSI Pharmaceuticals, Inc.
PowerVision, Inc.
Regeneron Pharmaceuticals, Inc.
Seiko Epson Corporation
Sensimed SA
Shanghai Weicon Optics Co., LTD.
STAAR Surgical Co.
Taiwan Liposome Company Ltd.
TopCon Corporation
Tomey Corporation
Transcent Medical, Inc.
Vision Solution Technologies, Inc.
Valeant Pharmaceuticals International, Inc.
WaveTec Vision (Novartis International AG)
Other Organisations Mentioned in this Report
Food and Drug Administration (US)
Japanese Ministry of Health, Labour, and Welfare (MHLW)
Japanese Pharmaceutical and Medical Devices Agency (PMDA)
Mexican National Institute of Statistics and Geography (INEGI)
US Preventive Service Task Force (USPSTF)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Ophthalmic Devices Market Forecast 2015-2025
Download sample pages
Complete the form below to download your free sample pages for Ophthalmic Devices Market Forecast 2015-2025
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
The rising prevalence of oncological disorders, lung infections, rising demand for customised drugs coupled with new orphan diseases discoveries, are few of the major reasons responsible for development of pharmaceutical spray drying market.
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.
Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.
Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031
Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
